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SELF-HEALING POLYMER MATERIALS course, any material that could self heal in an inflatable
FOR WIRE INSULATION, POLYIMIDES, barrier in space would also have uses in inflatable structures
FLAT SURFACES, AND INFLATABLE on earth, as well as in other types of structures.
STRUCTURES New self-healing materials are needed for uses that
5 include wire insulation, healing polyimides, especially aro-
CROSS-REFERENCE TO RELATED matic polyimides, and healing inflatable structures to stop or
APPLICATIONS prevent gas leakage.
This application claims the benefit under 35 U.S.C.
§ 119(e) of U.S. Provisional Application Ser. No. 61/497, 10
614, filed on Jun. 16, 2011, the contents of which are
incorporated herein by reference.
STATEMENT OF GOVERNMENT INTEREST
15
The invention described herein was made in the perfor-
mance of work under a NASA contract and by an employee
of the United States Government and is subject to the
provisions of Public Law 96-517 (35 U.S.C. § 202) and may
be manufactured and used by or for the Government for 20
governmental purposes without the payment of any royalties
thereon or therefore. In accordance with 35 U.S.C. § 202, the
contractor elected not to retain title.
HLITO1601K6181►1DZ6]=III=1►Wa011 to] ►iI
Electrical wires generally contain an inner metal conduc-
tor surrounded by an insulation material. The insulation
becomes more brittle with age, and can crack or develop
defects due to age, heat, exposure to strong electrical fields, 30
and friction with other wires or surrounding objects or
surfaces. Problems in electrical wiring systems are an impor-
tant threat to the safety of spacecraft and aircraft, as well as
other electrical devices. An electrical short in power bus
wiring shortly after takeoff of Space Shuttle mission STS-93 35
resulted in loss of redundant main engine controller func-
tion. Arcing wire was blamed for the catastrophic losses of
TWA Flight 800 and SwissAir Flight 111.
Polyimides are high performance polymers that have been
used as wire insulation in demanding applications that have 40
low tolerance for failure, such as space travel and aeronau-
tics. The standard wire insulation for spacecraft and aircraft
is polyimide, particularly KAPTON. Polyimides have excel-
lent thermal stability and strength. Many hours are also
expended in the repair and inspection of electrical wiring in 45
an attempt to prevent wire failure.
Wire insulation with a built in self-healing capability
would improve the safety of systems containing electrical
wiring. Such insulation would require less inspection and
repair time over the lifetime of the system. 50
All engineered materials eventually fail. They then must
be replaced or repaired. A goal of this work is new self-
healing materials that will repair themselves when they are
damaged. An identified use for these new high performance
self-healing materials is self-healing wire insulation. This 55
would reduce the need for manual wire insulation repair and
replacement and reduce the risk of failures, such as electrical
shorts, that can result in loss of life.
A second area where self-healing would be desirable is
inflatable structures, both terrestrial and space applications. 60
Inflatable habitats are planned for use in space exploration.
Inflatable habitats face risks of damage and puncture from
micrometeroids and orbital debris externally, as well as
potentially internally from movement of persons and equip-
ment inside the structure. The ability to heal and seal an 65
inflatable structure to prevent gas escape or to stop gas
escape quickly after a puncture happens is a high priority. Of
SUMMARY OF THE INVENTION
One embodiment provides a polymer material comprising
a low-melt polymer matrix that melts at a temperature below
300° C.; and a first set of microcapsules comprising an outer
wall and an inner compartment, wherein the inner compart-
ment comprises a volatile solvent that when released from
the microcapsules melts or softens the polymer matrix.
One embodiment of the invention provides a polymer
material comprising a low molecular weight polymer matrix
and a first set of microcapsules comprising an outer wall and
an inner compartment, wherein the inner compartment com-
prises a volatile solvent that when released from the micro-
capsules melts or softens the polymer matrix. In this way,
damage to the material breaks open the microcapsules,
releasing their solvent. The solvent melts or softens the
surrounding polymer matrix allowing it to flow in the defect
caused by the damage. The solvent then evaporates, leaving
more solidified polymer in the defect that heals the defect.
Another embodiment provides a polymer material com-
prising a polymer matrix that flows at approximately 23° C.,
or about room temperature, wherein the polymer of the
polymer matrix is formed by polymerization of monomers
comprising: (a) a diamine monomer comprising repeating
alkyleneoxy segments of 2 to 6 carbon atoms or repeating
siloxy segments and having a molecular weight of between
250 and 3,000; and (b) a dianhydride monomer, wherein if
the polymer material is cast as a film and the film is cut into
two pieces, and the two pieces are placed laterally near to or
in contact with each other, the pieces of the film flow back
together at approximately 23° C., or about room tempera-
ture, within 30 days and molecularly combine.
By "molecularly combine" it is meant that the polymer
molecules in the two pieces of material intermingle such that
the cut is no longer visible over at least part of its length and
the previously separated pieces do not pull apart as easily,
i.e., have some tear resistance. In some cases, the material
may have nearly the same tear resistance, or material
strength, as before it was cut into two pieces.
Another embodiment provides a polymer material com-
prising a polymer matrix that flows at approximately 23° C.,
or about room temperature, wherein the polymer of the
polymer matrix is formed by polymerization of monomers
comprising: (a) a diamine or diol monomer comprising
repeating alkyleneoxy segments of 2 to 6 carbon atoms or
repeating siloxy segments and having a molecular weight of
between 250 and 3,000; and (b) a diisocyanate monomer,
wherein if the polymer material is cast as a film and the film
is cut into two pieces, and the two pieces are placed laterally
in contact with each other, the pieces of the film flow back
together at approximately 23° C., or about room tempera-
ture, within 30 days and molecularly combine.
Another embodiment provides microcapsules comprising
an outer wall and an inner compartment; wherein the outer
wall is a polyimide, and the inner compartment comprises a
poly(amic acid) (PAA); and wherein the polyimide is formed
from the PAA. The microcapsules can be formed by a
process comprising: forming an emulsion of an oil phase
containing PAA in an aqueous phase; and adding an acid
US 10,174,198 B2
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anhydride to the emulsion to imidize the PAA and form
microcapsules, wherein the microcapsules have an outer
shell of a polymide formed from the PAA and the acid
anhydride, encasing a liquid PAA interior. PAA is highly
compatible with polyimides, and is converted to polyimide 5
by heating. So PAAs are desirable as a healing agent with
polyimide. This method forms microcapsules with a PAA
interior cargo, and a polyimide wall. The polyimide wall
also is compatible with the polyimide matrix, so the micro-
capsules are evenly dispersed. 10
Another embodiment provides a self-healing polymer
material comprising: (a) a polyimide matrix, wherein the
polyimide has an excess of one reactive end group selected
from the group consisting of amine and anhydride; and (b)
microcapsules comprising a healing agent that is a mono- 15
mer, prepolymer, or polymer, the healing agent having an
excess of the other reactive end group not in excess in (a)
selected from the group consisting of amine and anhydride.
In this way, when the microcapsules break because of
damage to the material, they release a monomer or prepoly- 20
mer having one type of reactive end group which reacts with
the compatible type of reactive end group that is found on
the polymer matrix, to make new polyimide that fills and
heals the damage.
Another embodiment provides a self-healing polymer 25
film comprising: (a) a polyimide matrix; and (b) microcap-
sules dispersed in the polyimide matrix and having a wall
and an inner compartment, the inner compartment compris-
ing a solvent and a compatible low-melt polyimide.
Another embodiment provides a polymer material com- 30
prising: (a) a low-melt polyimide matrix; and (b) microcap-
sules having a wall and an inner compartment, wherein the
inner compartment comprises: (i) a solvent that is released
from the microcapsules when the microcapsules break, and
melts or softens the low-melt polymer matrix at approxi- 35
mately 23° C., or about room temperature; or (ii) a healing
agent selected from the group consisting of a reactive
monomer, a prepolymer, a low-melt polymer, and combina-
tions thereof; or (iii) both (i) and (ii).
Another embodiment provides a laminate composite 40
structure comprising: two strong polymer film layers, each
in contact with a flowable self-healing polymer film layer
between the two strong polymer film layers; wherein the
strong polymer film layers are mechanically stronger than
the self-healing polymer film layer; wherein upon a break 45
through the three polymer film layers, the self-healing
polymer forms an air-tight seal in the composite structure;
wherein the flowable self-healing polymer film layer is a
polyimide, polyurea, polyurethane, polyamide, or polyester.
In a more specific embodiment, the self-healing polymer 50
film layer is a polyimide, polyurea, or polyurethane.
Another embodiment provides a fluid-containing object
comprising: a wall comprising the laminate composite struc-
ture described above, wherein the laminate composite struc-
ture surrounds or holds a fluid. 55
Another embodiment provides a wire comprising: a cen-
tral metal conductor surrounded by polymer insulation;
wherein the polymer insulation comprises the laminate
composite structure described above.
Another embodiment provides a polymer material com- 60
prising: (a) a polymer matrix; and embedded in the matrix,
(b) microcapsules wherein the microcapsules are formed by
a process comprising reacting an initial mixture of
melamine, formaldehyde, and pentaerythritol tetra(3-mer-
captopropionate) (PTT) to form a first batch of microcapsule 65
shell wall prepolymer, and polymerizing the first batch of
prepolymer to form a first microcapsule wall layer; and
4
subsequently reacting a second batch of melamine, formal-
dehyde, and PTT to form a second batch of prepolymer and
polymerizing the second batch of prepolymer to form a
second microcapsule wall layer.
It was found that microcapsules can have their inner
contents extracted when coming in contact with various
solvents or can even directly leak their contents during the
casting or manufacture of a polymer composite comprising
microcapsules. Microcapsules formed with a double layer
wall formed as described above, were found to have much
lower leakage when they were cast into polymer films.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1. Progression of photographs demonstrating the
self-healing/sealing properties of polyimide BPADA/XTJ-
542/ODA/MAA (9:7:3:2; Table 1, Item 2) Over Time. A thin
film, roughly 10-mil thick, was placed on a glass slide and
cut through with a razor blade. The initial cut was approxi-
mately 50 micrometers wide.
FIG. 2. Self-healing of polyimide BPADA/XTJ-542/
ODA/CSSuccan (9:7:3:2; Table 1, Item 6).
FIG. 3. Self-healing of polyimide BPADA/XTJ-542/ODA
(4:3.5:1.5; Table 1, Item 5).
FIG. 4. Self-healing of polyimide BPADA/XTJ-542/
TDA/Succan (9:7:3:2; Table 1, Item 17).
FIG. 5. Self-healing of polyurethane IPDI/Siloxane Diol
(9:10; Table 1, Item 24).
FIG. 6. Microcapsules (Table 2, Item 1) (400x).
FIG. 7. Diagram of a laminate composite structure of the
invention.
FIG. 8. Self-healing of laminate composite (Table 4, Item
2).
FIG. 9. Thermogravimetric analysis (TGA) of polyimide
BPADA/XTJ-542/ODA/MAA (9:7:3:2; Table 1, Item 2) and
polyimide BPADA/XTJ-542/ODA/MAA (9:7:3:2; Table 1,
Item 3) films cured at 150° C. and 200° C. (Table 1, Items
2 and 3).
FIG. 10. TGA comparison of film/capsule composite
components (Table 3, Item 1).
FIG. 11. Micrograph of self-healing/sealing film after
puncture damage.
FIG. 12. Micrograph showing self healing of polyimide
BPADA/XTJ-542/ODA/MAA (9:7:3:2; Table 1, Item 3)
(150° C. cure) after surface damage with a needle. Clock-
wise from upper left, panels show the material at 0 minutes
after damage (initial), 1 minute, 3 minutes, and 2 minutes
after damage.
FIG. 13. Micrograph showing self healing of polyimide
BPADA/XTJ-542/ODA/MAA (9:7:3:2; Table 1, Item 3)
(200° C. cure) after surface damage with a needle. Clock-
wise from upper left, panels show the material at 0 minutes
after damage (initial), 1 minute, 3 minutes, and 2 minutes
after damage.
FIGS. 14A, 14B, and 14C. Chemical structures and
acronyms referenced in this document.
DETAILED DESCRIPTION OF THE
INVENTION
The polyimide of polyimide wire insulation are of the
formula below, where R together with R' or R" or both, form
the polymer backbone. The polyimide of wire insulation is
ordinarily an aromatic polyimide, i.e., a polyimide where R'
and R" in the polyimide structure below are two carbon
atoms of aromatic rings.
5R
~N~
R' R"
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Poly(amic acid)s (PAAs) are of the form below, where R
and either R' or R" or both together form the polymer
backbone. With heating, the PAAs can imidize to the cor-
responding polyimide (PI), as shown below.
O O
H
R-N R-N
R' 
- R'
HO o
O R" R"
PAA PI
As used herein, an "aromatic" compound is a compound
that has any aromatic structure, and an "aliphatic" com-
pound is a compound that has no aromatic structure.
Low-Melt Polyimides for Self-Healing Films or Layers
One goal of this work is self-healing thin films, i.e., a
polymer layer of 10 microns to 5 mm in thickness. More
preferably the films are 50 microns to 5 mm, 50 microns to
3 mm, or 100 microns to 3 mm in thickness. Self-healing,
high performance polymer materials that have excellent
electrical, chemical, and thermal properties are especially
desired. Polyimides, such as KAPTON, are common high
performance polymers. They are used in wire insulation in
aerospace and aviation, in military vehicles, and in other
uses.
We have developed flowable polyimides that have a
tendency, when cut, for the separated edges to slowly flow
back together and form a seal again. We have found that
microcapsules can be included in these materials to further
assist the process. One type of microcapsule comprises a
volatile solvent that, when released from the microcapsule,
melts or softens the polymer matrix to fill in a void. Another
type comprises a healing agent that can fill a defect in the
polymer matrix or react with the polymer matrix to help heal
the damage to the matrix.
Thus, one embodiment provides a polymer material com-
prising a low-melt polymer matrix; and a first set of micro-
capsules comprising an outer wall and an inner compart-
ment, wherein the inner compartment comprises a volatile
solvent that, when released from the microcapsules, melts or
softens the polymer matrix.
The low-melt polymer matrix melts below 300° C., pref-
erably below 250° C., more preferably below 200° C., more
preferably below 150° C., and in some cases below 100° C.
In specific embodiments, the low-melt polymer matrix
consists of polymer with an average molecular weight below
100,000, below 75,000, below 50,000, or below 25,000
Daltons.
In other embodiments, the polymer matrix may consist of
a polymer with 2 to 1,000,000 repeat units.
Another embodiment provides a polymer material com-
prising a low-melt polymer matrix and a first set of micro-
capsules comprising an outer wall and an inner compart-
ment, wherein the inner compartment comprises a healing
agent selected from the group consisting of a monomer with
reactive end groups, a prepolymer, and a polymer. The
6
prepolymer and polymer may optionally also have reactive
end groups. The polymer matrix may also optionally have
reactive end groups.
In a preferred embodiment, the polymer matrix is, or
5 comprises, a polyimide. Polyimides are typically formed by
reaction of a dianhydride and a diamine. So the reactive end
groups on the polymer matrix, the reactive monomer, and
the prepolymer or polymer contained in the microcapsules
may be an amine or anhydride. These two groups will react
io to form an amide bond and a PAA. The PAA may cyclize to
convert the amide bond to an imide and form a polyimide.
In other embodiments the polymer matrix is a polyure-
thane, a polyamide, a polyester, or a polyurea.
There may be microcapsules with two types of reactive
15 healing agents, one with amine groups and one with anhy-
drides. For instance, one type of microcapsule may have a
diamine monomer and, another type in the same material, a
dianhydride monomer. When both types of microcapsules
break, the two monomers will react to form new polyimide,
20 polyamide, or PAA to heal the damage.
In other types of materials, the material may contain one
type of microcapsule with a monomer, prepolymer, or poly-
mer with a first type of reactive end group, and a second type
of microcapsule with monomer, prepolymer, or polymer
25 with a second type of reactive end group, wherein the first
and second types of reactive end groups will react with each
other to form a covalent bond. In a preferred embodiment,
the first reactive end group is an amine and the second is an
anhydride, and the covalent bond is an amide or imide.
30 In other embodiments, the polymer matrix has an excess
of a first type of reactive end group, and the microcapsules
comprise a wall and an inner compartment, wherein the
inner compartment comprises a monomer, prepolymer, or
polymer with a second type of reactive end group, wherein
35 the first and second types of reactive end groups will react
with each other to form a covalent bond.
In a specific embodiment, the polymer material is an
insulation layer of an electrical wire.
In a specific embodiment, the polymer matrix of the
40 polymer material is a polyimide. In a more specific embodi-
ment, it is an aromatic polyimide.
Low-melt polyimides can be prepared as described in
U.S. Patent Application Publication US 2011/0212334
entitled "Low-Melt Poly(amic acids) and Polyimides and
45 their Uses," published on Sep. 1, 2011, and U.S. Provisional
Patent Application Ser. No. 61/658,058 entitled "Low-Melt
Poly(amic acids) and Polyimides and Their Uses," filed on
Jun. 11, 2012, the contents of both are incorporated herein
by reference. They can be prepared, for instance, by polym-
50 erization of monomers comprising a diamine monomer
comprising repeating alkyleneoxy segments of 2 to 6 carbon
atoms or repeating siloxy segments and having a molecular
weight of between 250 and 3,000. In a more specific
embodiment, the diamine monomer has a molecular weight
55 of between 500 and 1,600. The use of end caps that shorten
the length of the polyimides, such as maleic anhydride,
succinic anhydride, and other monoanhydrides or monoam-
ines also yield low-melt polyimides, even without necessar-
ily including diamine monomers comprising repeating alky-
60 leneoxy segments of 2 to 6 carbon atoms or repeating siloxy
segments and having a molecular weight of between 250 and
3,000.
In a specific embodiment of a polymer material compris-
ing a low-melt polymer matrix, the material further com-
65 prises a set of microcapsules with an outer wall and an inner
compartment, wherein the inner compartment comprises a
flowable polymer. The flowable polymer may be a low-melt
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polymer. It may be the same polymer as the low-melt
polymer matrix. Upon breakage of the microcapsules, the
flowable polymer flows into any damaged areas of the
material to heal the material. The flowable polymer may or
may not have reactive end groups or otherwise react with the 5
polymer matrix.
The set of microcapsules with a flowable polymer may be
in addition to, or instead of, a set of microcapsules that
comprises a volatile solvent that when released from the
microcapsules melts or softens the polymer matrix. 10
In one embodiment of the polymer material comprising a
low-melt polymer matrix and a first set of microcapsules
having a volatile solvent that melts or softens the polymer
matrix, the material further comprises a second set of
microcapsules comprising an outer wall and an inner com- 15
partment, wherein the inner compartment comprises a pre-
polymer having reactive end groups.
In another embodiment, the material further comprises a
third set of microcapsules comprising an outer wall and an
inner compartment, wherein the inner compartment com- 20
prises a monomer having end groups that react with the
reactive end groups of the prepolymer in the second set of
microcapsules, wherein one of the prepolymer and the
monomer reactive end groups is an anhydride and the other
is an amine. 25
In one embodiment of the polymer material comprising a
low-melt polymer matrix and a first set of microcapsules
having a volatile solvent that melts or softens the polymer
matrix, the inner compartment of the first set of microcap-
sules further comprises a microcapsule polymer dissolved in 30
the solvent, wherein when the solvent dissolves or softens
the polymer matrix after microcapsule breakage, the micro-
capsule polymer heals damage to the polymer matrix.
When the capsules with a solvent or a healing agent
release their contents, the released material allows the heal- 35
ing process to occur faster and cover a larger surface area.
If a solvent is included, it must possess the ability to either
dissolve, at least to some extent, or plasticize the polymer
matrix. It must also be volatile enough to evaporate from the
healed area but have a boiling point high enough to remain 40
in the polymer matrix or film long enough for it to cause the
desired increase in flow. As a general guideline, the boiling
point should be between about 125° C. and 250° C. for a
desirable solvent. The solvent can also contain a low level of
polymer dissolved therein, which can remain behind and 45
help seal or heal the damage upon evaporation of the
solvent.
The self-healing characteristics can be enhanced by the
design or construction of the film or layer for wiring
applications. Laboratory proof of concept demonstrations 50
indicate that the flowable properties can be maximized if
significant tension is not placed upon the layer. Thus, a
sleeve should work better than a tightly wrapped overlayer.
It was observed that a film wrapped around the longitudi-
nally along a wire has less tension than a film wrapped in a 55
lateral swirl around the wire, and thereby allows for better
self-sealing to occur.
The self-sealing properties of a low-melt polyimide
matrix with microcapsules containing a volatile solvent,
methyl benzoate, were tested on various surfaces. It was 60
most successful in sealing after the film was cut on glass,
KAPTON, and copper-coated tape. It was less successful on
nickel-coated carbon fiber, OASIS tape, and TEFLON.
Another embodiment provides a polymer material com-
prising: (a) a low-melt polyimide matrix; and (b) microcap- 65
sules having a wall and an inner compartment, wherein the
inner compartment comprises: (i) a solvent that is released
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from the microcapsules when the microcapsules break, and
melts or softens the low-melt polymer matrix at or about
room temperature; or (ii) a healing agent selected from the
group consisting of a reactive monomer, a prepolymer, a
low-melt polymer, and combinations thereof; or (iii) both (i)
and (ii). By the term "melts or softens" we mean that the
release of the solvent causes some measurable and useful
increase in flow of the polymer matrix locally at the site of
solvent release. This may be by partially dissolving the
polymer matrix.
In a more specific embodiment, the polymer material
comprises at least two types of microcapsules: a first type
comprising a healing agent with a first type of reactive end
group, and a second type comprising a healing agent with a
second type of reactive end group; wherein when released
from the microcapsules the first type of healing agent reacts
with the second type of healing agent to form a polymer that
heals defects in the polymer material.
The present invention relates in part to the preparation of
PAAs or polyimides with significantly lower melting/soft-
ening temperatures. One way the inventors have found to
achieve that is by mixing two or more PAAs or polyimides
together. Due to melting point depression, the melting
temperature of the resulting mixture is significantly lower
than the melting point of the polymer component with the
highest melting temperature, and often lower than the melt-
ing temperature of both polymer components or all polymer
components of the mixture.
Typically, the polymer mixture is prepared as detailed
hereafter. The two PAAs or polyimides chosen as compo-
nents in the mixture are blended by mixing individual fluids
containing the component PAAs or polyimides or by mixing
the individual solid PAAs or polyimides with a given
amount of suitable solvent such as N-methyprrolidinone
(NMP). The newly created mixture is stirred at room tem-
perature until the entire polymer has dissolved. This polymer
solution can then be used to cast polymer films or to be
processed to isolate the solid polymer mixture. A polyimide
mixture can be prepared by first preparing a mixture of
PAAs as described here, and then heating the PAA mixture
to cyclize the PAAs into polyimides.
High performance polyimide polymers used today in
applications such as electrical wire insulation are prepared
from aromatic monomer starting materials. Polyimides pre-
pared from aliphatic monomers do not possess the same
degree of excellent electrical, chemical, and thermal prop-
erties as their aromatic counterparts. Many PAA precursors
prepared from aliphatic monomers do have, however, melt-
ing points far lower than those prepared from aromatic
monomers. Thus, PAAs with sufficiently low melting points,
that still polymerize to a polyimide with good physical
properties for insulation strength, flexibility, resistance to
abrasion, and high or no melting temperature can be
produced in at least two ways: by mixing two or more PAAs
and thereby producing a mixture that has a lower melting
temperature than at least one of the PAAs, or by incorpo-
rating an appropriate blend of aliphatic and aromatic mono-
mers in making a single PAA backbone. Increased aliphalic-
ity of the monomers and the PAA gives the PAA a lower
melting temperature. Low-melting polyimides can be pre-
pared also by incorporating aliphalicity into the polyimides
or generating a mixture of polyimides that has a lower
melting point than either or both polyimides of the mixture.
A typical PAA of the invention that combines an appro-
priate blend of aliphatic and aromatic monomers in a single
backbone is prepared in the following manner. An aromatic
diamine (or mixture of aliphatic and aromatic diamines) is
US 10,174,198 B2
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dissolved into a suitable solvent such as NMP. The mixture
is held at room temperature and is stirred under nitrogen. An
aromatic dianhydride (or mixture of aliphatic and aromatic
dianhydride) is slowly added to the diamine mixture. An
exothermic reaction ensues which is minimized by the slow
monomer addition and/or cooling. After the dianhydride has
all been added, the mixture is stirred for a number of hours
to complete the polymerization. The newly created polymer
solution can then be cast into polymer films or processed to
isolate the solid polymer. The PAA can be heated to cyclize
it and convert it to a low-melt polyimide suitable for use in
self-healing.
In another embodiment, the inventors have found that
polyimides containing either siloxane or polyether chemis-
try are effective low-melt polymers for self-healing. PAAs
having siloxane or polyether chemistry also have the same
advantages.
Many physical properties have to be met in order for a
polyimide to be useful for self-healing. Two desirable prop-
erties are flexibility and a low melting point. It has been
determined that films with increased flexibility can be
obtained through the incorporation of polyether moieties or
through the use of silicon in the form of siloxane chemistry
as part of the backbone of PAAs and polyimides. Some of
the films comprising the present invention have final poly-
imides that are also flexible and have relatively low melting
points. It has been determined that these flexible polyimide
films are adaptable for use as repair materials and are
flowable for self-healing.
A typical polyimide is prepared by reacting equal molar
amounts of two starting materials (i.e., a dianhydride and a
diamine). These molecules react alternately with one
another when mixed until a polymer with a molecular
weight of several hundred thousand is produced. Such a
polymer, by itself, is often too high in molecular weight to
melt or function well for self-healing. Average molecular
weights of below 50,000, preferably below 20,000 are
needed for a resin to exhibit the needed melt and flow
properties necessary for self-healing. End cap molecules
such as maleic anhydride can function as chain termination
molecules and produce resins that will form good films.
With heating, the polymers with maleic anhdyride end caps
cross-link through the olefinic group of maleic anhydride to
produce a higher molecular weight polymer.
Other end-cap groups that also have olefinic nature can be
substituted for maleic acid, including allyl alcohol, vinyl
amine, allyl amine, acrylic acid, methacrylic acid, and the
like.
In specific embodiments, the low-melt polymer comprises
a polyimide with reactive end groups; wherein at the second
temperature, the polyimide with reactive end groups reacts
through its reactive end groups to form a repair polyimide.
The end groups may also react with the polymer substrate so
the repair polyimide is covalently bonded to the polymer
substrate. The reactive end groups in specific embodiments
are olefinic groups. In specific embodiments, the reactive
end groups are olefinic organic acid end caps, for example
maleic acid end caps resulting from reacting with maleic
anhydride. In specific embodiments, the reactive end groups
are groups resulting from end-capping reactions with acrylic
acid (forming an acrylic acid salt with amino or other
positively charged groups on the polymer), methacrylic acid,
allyl alcohol, allyl amine, vinyl amine, and maleic or
itaconic anhydride.
In other embodiments, the reactive end groups have free
amine or anhydride groups.
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In specific embodiments of the methods and materials and
articles disclosed herein, the low-melt polymer or low-melt
polymer layer comprises a mixture of at least two PAAs or
at least two polyimides.
5 In specific embodiments, the mixture of two PAAs or at
least two polyimides melts at a lower temperature than at
least two of the at least two PAAs or polyimides.
In particular embodiments, the low-melt polymer com-
prises a PAA or a polyimide having reactive end groups, or
io a polyimide comprising polyether blocks or polysiloxane
blocks in the polymer backbone.
The PAA in specific embodiments also has reactive end
groups.
In specific embodiments, the PAA comprises polyether or
15 polysiloxane blocks.
Where the PAA or polyimide comprises polyether blocks,
the polyether blocks in specific embodiments have the
structure (C2-C6)alkyl-[O (C2-C6)alkyl-] O (CZ-C6)
alkyl-. In other embodiments, the polyether blocks have the
20 structure (C4 C6)alkyl-[O (C4-C6)alkyl-] O (C4-C6)
alkyl-. In specific embodiments, the polymer is formed by
reacting a diamine and a dianhydride, where the diamine has
the structure H2N (C2-C6)alkyl-[O (C2-C6)alkyl-] O
(C2-C6)alkyl-NH2. In other embodiments, the diamine has
25 the structure H2N (C4 C6)alkyl-[O (C4-C6)alkyl-] O
(C4-C6)alkyl-NH2.
Where the PAA or polyimide contains polysiloxane
blocks, the polysiloxane blocks in specific embodiments
have the structure (C2-C6)alkyl-O Si(CH3)2 [O Si
30 (CH3)2-] O Si(CH3)2 O (C2-C6)alkyl-. In specific
embodiments, the polymer is formed by reacting a diamine
and a dianhydride, where the diamine has the structure
H2N (C2-C6)alkyl-O Si(CH3)2 [O Si(CH3)2-] O Si
(CH3)2 0 (C2-C6)alkyl-NH2.
35 In specific embodiments, 15% to 60% of the carbon atoms
of the low-melt polymer are in polyether or polysiloxane
blocks.
In specific embodiments, the PAA mixture is formed by a
process comprising: dissolving the at least two PAAs into a
40 compatible solvent to form a PAA solution; and evaporating
at least some of the solvent to form a solidified PAA mixture.
In specific embodiments, the polyimide mixture is formed
by a process comprising: dissolving the at least two poly-
imides into a compatible solvent to form a polyimide
45 solution; and evaporating at least some of the solvent to form
a solidified polyimide mixture.
In specific embodiments, the low-melt polymer is formed
from a reaction mixture of monomers, wherein at least 15%
by weight of the monomers are fully aliphatic, defined
5o herein as not aromatic.
In specific embodiments, at least 15% of carbon atoms in
the low-melt polymer are aliphatic carbon atoms (defined
herein as not being a ring carbon of an aromatic ring). In
other specific embodiments, 15% to 60% of carbon atoms in
55 the low-melt polymer are aliphatic.
In specific embodiments, the low-melt polymer has a
melting temperature of 70° C. to 170° C. In other embodi-
ments, the low-melt polymer has a melting temperature of
70° C. to 150° C. In specific embodiments, the low-melt
60 polymer has a melting temperature of 70° C. to 200° C., 70°
C. to 250° C., or 70° C. to 300° C.
In specific embodiments, the low-melt polymer layer
comprises a cross-linker. In specific embodiments, the cross-
linker is a residue of acrylic acid, methacrylic acid, allyl
65 alcohol, allyl amine, vinyl amine, or maleic anhydride.
In specific embodiments of the low-melt polymers having
reactive end groups, the reactive end groups are selected
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from the group consisting of anhydrides, carboxylic acids,
esters, amines, alcohols, isocyanates, epoxides, olefins, and
dienes.
In specific embodiments of low-melt polymers with reac-
tive end cap groups, the reactive end cap groups may be
olefinic end cap groups. In more specific embodiments, they
are olefinic organic acid end cap groups, e.g., maleic acid
groups produced by reaction of maleic anhydride.
In specific embodiments, the low-melt polymer comprises
olefinic organic acid end caps formed by including an acid
anhydride comprising an olefin group in a polymerization
reaction to form the low-melt polyimide or PAA.
In specific embodiments of the methods, materials, and
apparatuses disclosed herein, the low-melt polymer has an
average molecular weight below 50,000, more preferably
below 20,000.
One embodiment of the invention provides a method of
forming a PAA or a polyimide comprising: reacting a
dianhydride and a diamine in a polymerization reaction
mixture to form a PAA; wherein the dianhydride is a
dianhydride of formula 1,
RI RI RI RI
RZ
RI O \ / \ / O RI
O Rz O
\ / RI RI RI RI
I
-
RI R 
O O
R, R,
O O
wherein each R, is independently H or (Cl-C4)alkyl, and
each Rz is independently H or (Cl-C4)alkyl;
or wherein the diamine is a diamine of formula 2 or 3
H2N (Cz C6)aikyi-[o (Cz C6)aikyi-]nO—
(Cz C6)alkyl-NHz (2)
H2N (Cz C6)alkyl-0—Si(CH3)z [O
Si(CH3)2 ]„0—Si(CH3)z_0_
(Cz C6)alkyl-NHz; (3)
wherein at least 50% by weight of reactants in the
polymerization reaction mixture are a compound of
formula 1, 2, or 3 or a combination thereof.
The PAA may be heated to convert it to a polyimide.
In a specific embodiment, the compound of formula 1 is
bisphenol A dianhydride (BPADA), where each of the R,'s
is hydrogen and each of the Rz's is methyl (see Example 1
below).
In a specific embodiment, the compound of formula 2 is
XTJ-542 (see Example 1 below).
In a specific embodiment, the compound of formula 3 is
diaminopolysiloxane (DAPS) (see Example 1 below).
In a preferred embodiment, the dianhydride is a com-
pound of formula 1 and the diamine is a diamine of formula
2or3.
In specific embodiments, at least 60%, at least 70%, or at
least 80% of reactants in the polymerization reaction mix-
ture are a compound of formula 1, 2, or 3, or a combination
thereof.
Low-Melt Polyureas and Polyurethanes
In another embodiment, the inventors have found that
polyureas and polyurethanes containing either siloxane or
polyether chemistry are effective low-melt polymers for
self-healing, similarly to the polyimides described herein.
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A typical polyurea and polyurethane is prepared by react-
ing equal molar amounts of two starting materials (i.e., a
diisocyanate and a diamine or diol).
In specific embodiments, the low-melt polymer comprises
5 a polyurea or polyurethane with reactive end groups.
In specific embodiments, the reactive end groups are free
amine, alcohol, or isocyanate groups.
In specific embodiments of the methods, materials, and
articles disclosed herein, the low-melt polymer or low-melt
10 polymer layer comprises a mixture of at least two polymers,
wherein the at least two polymers include one or more
polyureas or polyurethanes.
In specific embodiments, the mixture of two polymers
melts at a lower temperature than at least two of the at least
15 two polymers.
In particular embodiments, the low-melt polymer com-
prises a polyurea having reactive end groups or a polyure-
thane having reactive end groups.
In specific embodiments, the low-melt polymer comprises
20 a polyurea or polyurethane, wherein the polyurea or poly-
urethane comprises polyether blocks or polysiloxane blocks
in the polymer backbone.
Where the low-melt polymer comprises polyether blocks,
the polyether blocks in specific embodiments have the
25 structure (C2-C6)alkyl-[O (Cz-C6)alkyl-] O (Cz-C6)
alkyl-. In other embodiments, the polyether blocks have the
structure (C4 C6)alkyl-[O (C4-C6)alkyl-] O (C4-C6)
alkyl-. In specific embodiments, the polymer is formed by
reacting a diamine and a diisocyanate, where the diamine
30 has the structure H2N (C2-C6)alkyl-1O (Cz-C6)
alkyl-] O (Cz-C6)alkyl-NHz. In other embodiments, the
diamine has the structure H2N (C4 C6)alkyl-[O (C4-C6)
alkyl-] O (C4-C6)alkyl-NHz.
In specific embodiments, the polymer is formed by react-
35 ing a diol and a diisocyanate, where the diol has the structure
Ho (Cz-C6)alkyl-[o (Cz-C6)alkyl-]no (Cz-C6)alkyl-
OH. In other embodiments, the diol has the structure HO
(C4-C6)alkyl-lo (c4 C6)alkyl-]no (C4-C6)alkyl-OH.
Where the low-melt polymer contains polysiloxane
40 blocks, the polysiloxane blocks in specific embodiments
have the structure (C2-C6)alkyl-O Si(CH3)z [O Si
(CH3)2 ] O Si(CH3)z O (Cz-C6)alkyl-. In specific
embodiments, the polymer is formed by reacting a diamine
and a diisocyanate, where the diamine has the structure
45 H2N (Cz-C6)alkyl-O Si(CH3)z [O Si(CH3)z ] O
Si(CH3)z O (Cz-C6)alkyl-NHz.
In specific embodiments, the low-melt polymer is formed
by reacting a diol and a diisocyanate, where the diol has the
structure HO (Cz-C6)alkyl-O Si(CH3)z [O
50 Si(CH3)2 ]no Si(CH3)z o (Cz-C6)alkyl-OH.
In specific embodiments, 15% to 60% of the carbon atoms
of the low-melt polymer are in polyether or polysiloxane
blocks.
One embodiment of the invention provides a method of
55 forming a polyurea or polyurethane comprising: reacting (a)
a diisocyanate and (b) a diamine or diol in a polymerization
reaction mixture to form a low-melt polyurea or polyure-
thane; wherein the diisocyanate is an aliphatic diisocyanate,
for instance isophorone diisocyanate (IPDI); and wherein
60 the diamine is a diamine of formula 2 or 3
H2N (Cz C6)a<kYi-[o (Cz C6)aikyi-]nO—
(Cz C6)alkyl-NHz (2)
65 
H2N (Cz C6)alkyl-O Si(CH3)z [O
Si(CH3)2_ ] 0—Si(CH3)z_0_
(Cz C6)alkyl-NHz; (3)
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and wherein the diol is a diol of formula 4 or 5
Ho (Cz C6)alkyl-[o (Cz C6)alkyl-]nO—
(Cz C6)alkyl-OH, (4)
HO(Cz C6)alkyl-O—Si(CH3)z [O
Si(CH3)2 ]„O—Si(CH3)z_0_
(Cz C6)alkyl-OH; (5)
wherein at least 40% by weight of reactants in the
polymerization reaction mixture are a compound of
formula 2, 3, 4, or 5, or a combination thereof.
In a specific embodiment, the compound of formula 2 is
XTJ-542.
In a specific embodiment, the compound of formula 3 is
diaminopolysiloxane (DAPS).
In a specific embodiment, the compound of formula 5 is
siloxane diol.
Materials Development Self-Healing Films
Another embodiment provides a polymer material com-
prising a polymer matrix that flows at or about room
temperature, wherein the polymer of the polymer matrix is
formed by polymerization of (a) a diamine monomer com-
prising repeating alkyleneoxy segments of 2 to 6 carbon
atoms or repeating siloxy segments and having a molecular
weight of between 250 and 3,000; and (b) a dianhydride
monomer, wherein if the polymer material is cast as a film
and the film is cut into two pieces, and the two pieces are
placed in close proximity to each other, the pieces of the film
flow back together at or about room temperature within 30
days and molecularly combine.
By "close proximity" it is meant that the polymer edges
are within 100 microns of each other.
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By "molecularly combine" it is meant that the polymer
molecules in the two pieces of materials intermingle such
that the cut is no longer visible over at least part of its length
and the previously separated pieces do not pull apart as
5 easily, i.e., have some tear resistance. In some cases the
material may have nearly the same tear resistance, or mate-
rial strength, as before it was cut into two pieces.
A number of polymer compositions that we have inves-
tigated have exhibited self-healing properties. One such
material is prepared from the following components:
10 
BPADA, XTJ-542, ODA, and MAA at a mole ratio of
9:7:3:2 (Item 2 of Table 1) (refer to FIG. 14 for chemical
component definitions and to Table 1 for ratios).
This material, when cast as a film and heated to 150° C.,
imidizes and produces a thin film with highly elastic prop-
15 erties. It is also somewhat tacky and bonds to itself at the
slightest touch. FIG. 1 demonstrates the self-healing prop-
erties by showing the closure of a cut in a 10 mil thick film
roughly over several days time.
In view of these self-healing/sealing properties of Item 2
20 of Table 1, a number of other materials were prepared and
evaluated; some were within the polyimide family and
others were in the polyurea and polyurethane groups.
Although Item 2 of Table 1 exhibited both self-healing
behavior along with significant film-like structure, it was
25 desired that several physical properties of this film be
improved, if possible. A more desirable film would have a
faster rate of self-healing along with improved tensile
strength. Table 1 lists the sample identification formulations,
and the physical properties of the polymers produced in an
30 effort to obtain these improved properties. Formulations
with equivalent composition are shown in the comments
section of Table 1.
TABLE 1
Polvmer Chemical Compositions Evaluated for Self-healing Properties
Sample
Identification Chemical Components
Item STJ# (Appendix A) Ratio (m) Comments, Film Properties
1 11-69 BPADA/DAPS/ODA/MAA 9:8:2:2 Siloxane Polyimide Flexible
(SPIT)
2 11-44 BPADA/XTJ-542/ODA/MAA 9:7:3:2 Also 11-56, 86 & 95; NMP
solvent
3 11-77 BPADA/XTJ-542/ODA/MAA 9:7:3:2 Also 11-71; dimethyl
formamide solvent (DMF)
solvent
4 11-57 BPADA/XTJ-542/ODA 10:7:3 No End caps, slow self-healing
5 11-58 BPADA/XTJ-542/ODA 4:3.5:1.5 Partial Na Salt, ionomer
6 11-59 BPADA/XTJ-542/ODA/ 9:7:3:2 Alternate end caps, self-
C8Succan healing
7 11-60 BPADA/XTJ-542/DAD 9:6:4 11-44, 77 like; self-healing
8 11-80 BPADA/XTJ-542/ODA/MAA 9:7:3:1 Half of reactive endcaps, self-
healing
9 11-88 BPADA/XTJ-542/ODA/MAA/ 9:7:3:1:1 Half reactive-half unreactive,
Succan self-healing
10 11-92 BPADA/XTJ-542/ODA/Succan 9:6.5:3.5:2 Same properties as item 3
11 17-2 PMA/XTJ-542/ODA/MAA 9:7:3:2 Paste-like polyimide liquid
12 17-6 PMA/XTJ-542/ODA/MAA 9:6:4:2 Paste-like polyimide liquid
13 17-9 PMA/XTJ-542/ODA/MAA 18:13:6:23 Paste-like polyimide liquid
14 17-11 PMA/XTJ-542/ODA/Succan 9:5:5:2 Paste-like polyimide liquid
15 17-12 BPDA/XTJ-542/ODA/Succan 9:7:3:2 Paste-like polyimide liquid
16 17-15 BPDA/XTJ-542/ODA/Succan 9:4:6:2 Hazy, weak film, no self-
healing
17 17-17 BPADA/XTJ-542/TDA/Succan 9:7:3:2 Similar to #3, (11-77)
18 17-18 BPADA/XTJ-542/DASO/Succan 9:7:3:2 Slightly less self-healing than
#17
19 17-19 BPADA/XTJ-542/DABA/Succan 9:7:3:2 Weak film, no self-healing
20 11-72 TDI/XTJ-542 9:10 Polyurea - Fragile, no flow
21 11-74 TDI/DAPS 9:10 Polyurea - Tougher, no flow
22 11-75 IPDI/XTJ-542 9:10 Polyurea - self sealing
23 11-83 IPDI/DAPS 9:10 Polyurea - Slightly Self
sealing
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TABLE 1-continued
Polymer Chemical Compositions Evaluated for Self-healing Properties.
Sample
Identification Chemical Components
Item STJ# (Appendix A) Ratio (m) Comments, Film Properties
24 11-84 IPDUSiloxane Diet 9:10 Polyurethane; self sealing
25 11-89, 94 IPDUTerethane 1000 9:10 & 1:1 Polyurethane; liquid
26 11-78 BPADA/DAPS 1:1 Low viscosity liquid
Polymer chemical compositions, Items 1-19 in Table 1
began as PAAs dissolved in a solvent. With the exception of
Item 5, all were evaluated as films which were cast onto a
substrate and then baked at either 150° C. or 200° C. for
60-90 minutes (baking removes the solvent and converts the
PAA into a polyimide). A number of interesting facts were
observed between the building blocks used in these poly-
mers and the degree of flowable or self-healing properties
they have in final cast films. The most important factor
necessary to obtain a self-healing polymer is the inclusion of
a long flexible monomer such as a polyether diamine (e.g.,
XTJ-542) or polysiloxane diamine (e.g., DAPS). The use of
BPADA dianhydride also appears important in producing a
polyimide-type polymer which can be crafted into a film
having some structure, while also having the ability to flow
and seal small cuts or punctures. Several other dianhydrides
evaluated using these flexible diamines produced polymers
which had no structural integrity. Polymers listed in items
11-16 of Table 1 all had no, or very poor, film producing
ability.
Each of these polyimides in Table 1 also had, in its
formula, a second diamine co-monomer. In all cases except
one (Item 7) this co-monomer is an aromatic diamine. Only
one diamine co-monomer in this group produced a film with
no self-healing properties (Table 1, Item 19). The inclusion
of the aromatic diamine appears important in obtaining an
increase in tensile strength and thermal stability of the final
product. A number of these polyimide polymers were ini-
tially prepared with maleic anhydride end capping groups.
These maleic anhydride end caps are desirable in formula-
tions which are employed as primary wire insulation matri-
ces. In self-healing formulations with BPADA, XTJ-542,
ODA, and MAA (such as Table 1, Items 2 and 3), the
presence of these end caps is very noticeable when the
polymer is heated to the 150° C. imidization temperature and
above. Crosslinking of the polymer chains via thermal
polymerization of the end cap groups imparts a "memory" to
the polymer. This is similar to what is observed in polymers
such as vulcanized natural rubber which can be stretched
with the material returning to or near its original shape rather
than remaining in its earlier stretched length. The use of
succinic anhydride as an end-capping group eliminates this
phenomenon. The use of end caps aids in the preparation of
a lower molecular weight polymer which facilitates faster
self-healing.
Formulation Items 20-25 involve the use of isocyanate
reaction chemistry resulting in low molecular weight polyu-
reas and urethanes. The use of flexible diamine monomers
resulted in several materials which exhibit good self-healing
properties (Table 1, Items 22-24). These polymers also have
similar tackiness and flexibility with poor tensile strength as
is seen with the self-healing polyimides.
FIGS. 2-5 show the self-healing properties of selected
polymer chemical compositions from Table 1 (all cuts were
made similar to the polymer cut described in FIG. 1). Ridges
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observed in the first picture on the left of FIG. 2 were
transferred from the pad used to press the film; the flowable/
15 sealable properties of the film are observed as the cut and
ridges disappear over time.
Thus, again, one embodiment provides a polymer material
comprising a polymer matrix that flows at or about room
temperature, wherein the polymer of the polymer matrix is
20 formed by polymerization of (a) a diamine monomer com-
prising repeating alkyleneoxy segments of 2 to 6 carbon
atoms or repeating siloxy segments and having a molecular
weight of between 250 and 3,000, and (b) a dianhydride
monomer, wherein if the polymer material is cast as a film
25 and the film is cut into two pieces, and the two pieces are
placed in close proximity to each other, the pieces of the film
flow back together at or about room temperature within 30
days and molecularly combine. Here the polymers are
polyimides.
30 Another embodiment provides a polymer material com-
prising a polymer matrix that flows at approximately 23° C.,
or about room temperature, wherein the polymer of the
polymer matrix is formed by polymerization of monomers
35 comprising (a) a diamine or diol monomer comprising
repeating alkyleneoxy segments of 2 to 6 carbon atoms or
repeating siloxy segments, and having a molecular weight of
between 250 and 3,000; and (b) a diisocyanate monomer,
wherein if the polymer material is cast as a film and the film
40 is cut into two pieces, and the two pieces are placed laterally
in contact with each other, the pieces of the film flow back
together at or about room temperature within 30 days and
molecularly combine. Here the polymers are polyureas or
polyurethanes.
45 In a specific embodiment of the flowable polyureas and
polyurethanes, the diisocyanate monomer is an aliphatic
diisocyanate (e.g., IPDI).
In a specific embodiment, the diamine or diol monomer is
DAPS or siloxane diol.
50 In a specific embodiment of the flowable polyimides,
polyurethanes, and polyureas, the polymer material is a film
or layer 50 microns to 5 mm thick, or 100 microns to 3 mm
thick.
In specific embodiments, a film of the polymer material
55 250 microns thick (10 mils) when cut with a razor blade,
visually flows back together and molecularly combines over
more than 50% of the cut length within 24 hours at or about
room temperature.
The diamine monomers that were successfully tested in
60 generating these properties were XTJ-542 and DAPS. The
dianyydride tested was BPADA, an aromatic dianhydride.
In specific embodiments, the dianhydride is an aromatic
dianhydride. In a more specific embodiment, it is BPADA.
In other embodiments it is BPDA or benzophenone-3,3',4,
65 4'-tetracarboxylic dianhydride.
In specific embodiments, the monomers further comprise
an aromatic diamine monomer (e.g., ODA, DASO, or TDA).
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In specific embodiments, the monomers further comprise
an end capping group (e.g., MAA or Succan). MAA is
cross-linkable through its carbon-carbon double bond. Suc-
can does not have that double bond and is not cross-linkable.
As discussed above, the cross-linking of the polymer chains
via thermal polymerization of the end caps gives the mate-
rial a memory, like vulcanized rubber. But after cross-
linking it also increases the molecular weight of the polymer
material and makes it less flowable.
Thus, in specific embodiments, the end capping group is
not cross-linkable. In other embodiments it is. Either may be
desirable for different properties.
Microcapsules Containing PAAs
Another technique employed here for self-healing is to
encapsulate a healing agent in microcapsules and incorpo-
rate them into a polymer matrix, wherein the microcapsules
contain the healing agent. Aerospace wiring is one system
that would benefit from this. Older aerospace wire typically
utilizes a polyimide as the core insulation. Cracking and
breakdown of the polyimide material can cause electrical
anomalies and wire shorts.
To accomplish self healing in polyimide-type wire insu-
lation, it would be desirable to have microcapsules that
contain a polyimide or PAA (which is a precursor to poly-
imides). But some PAAs and polyimides have limited solu-
bility in solvents, making them difficult to encapsulate. The
solvents they are most soluble in are aprotic polar solvents
that are miscible with water and many other solvents.
Microcapsules containing PAA liquid interior encased in
a polyimide shell can, however, be created. One way to do
this is to make a solution of PAA in a water-immiscible
solvent such as methylbenzoate. The solution is then poured
into water or an aqueous solution with stirring. This creates
droplets of PAA/solvent in the water. Acetic anhydride or
another anhydride or imidization reagent can be added to the
water, or in some cases may be pre-dissolved in the water
before adding the PAA/solvent solution. The imidization
reagent causes imidization of the PAA at the droplet inter-
face, converting it to a polyimide on the droplet interface as
the imidization reagent contacts the surface of the droplets.
As most polyimides are less soluble in solvents than PAAs
the polyimide formed on the surface of the droplet will not
dissolve in the solvent/PAA mixture but will remain as a
solid shell at the water/droplet interface. This process creates
microcapsules with a polyimide shell encasing a liquid PAA
or liquid PAA/solvent interior.
An advantage of these microcapsules is that the polyimide
wall is highly compatible with a polyimide matrix, since
they are similar or the same material, and thus the micro-
capsules are easy to evenly disperse in a polyimide matrix.
Thus, one embodiment provides microcapsules compris-
ing an outer wall and an inner compartment; wherein the
outer wall is a polyimide, and the inner compartment com-
prises a PAA; and wherein the polyimide is formed from the
PAA.
In a more specific embodiment, the microcapsules are
formed by a process comprising: forming an emulsion of
PAA droplets in an aqueous phase; and reacting an imidiza-
tion reagent in the aqueous phase with PAA in the droplets
to form a polyimide and form microcapsules; wherein the
microcapsules have an outer shell of a polymide formed
from the PAA, encasing a liquid PAA interior.
The imidization reagent in specific embodiments can be
an acid anhydride or, more specifically, acetic anhydride.
In a specific embodiment, the step of forming an emulsion
of PAA droplets in an oil phase comprises forming a solution
of PAA in a solvent and stirring the solution in an aqueous
phase to form the emulsion.
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Polyimide and PAA Matrices with Reactive End Groups
A self-healing polymer material comprising a polyimide
matrix with microcapsules dispersed in the matrix, wherein
the microcapsules have an outer wall of a polyimide and an
5 inner compartment comprising a PAA; wherein when the
microcapsules rupture the PAA interior bonds with the
polyimide matrix. The bonding can be by chains of PAA
interspersing with polymer chains of the polymer matrix. Or
it may be by covalent reaction of reactive groups of the PAA
io with reactive side groups in the polymer matrix. The reactive
groups may be, for instance, the amic acid groups of PAA or
reactive end caps, such as vinyl residues from maleic
anhydride end caps, or amine or anhydride end groups.
Polyimides are prepared by the condensation reaction of
15 monomers that are di-functional. The basic reaction is the
condensation of a dianhydride and a diamine. We have found
that by adjusting the ratio of dianhydride to diamine, one can
produce polyimides with only anhydride or only amine
groups present at the ends of the polymer molecules. Such
20 end groups remain reactive and viable for some time, and
should a molecule come in contact with this viable end
group that is its reactive counterpart, then a reaction may
occur that will increase the length of the polymer chain.
The concept of this embodiment of the invention is a
25 polymer (polyimide or PAA) matrix with an excess of one
reactive end group selected from the group consisting of
amine and anhydride, and microcapsules containing a mono-
mer or low molecular weight prepolymer or low molecular
weight polymer having the complementary reactive group.
30 Should damage occur to the polymer matrix containing these
microcapsules, the microcapsules will break, releasing the
capsule contents, preferably in liquid form (possibly dis-
solved in a solvent) into the damaged area. The reactive end
groups of the polyimide matrix and the capsule core material
35 are then free to react together to provide a healing material
that is bonded intimately into the polymer matrix.
Thus, one embodiment provides a self-healing polymer
material comprising: (a) a polymer (polyimide or PAA)
matrix, wherein the polyimide has an excess of one reactive
40 
end group selected from the group consisting of amine and
anhydride; and (b) microcapsules comprising a healing
agent that is a monomer, prepolymer, or polymer, the healing
agent having an excess of the other reactive end group not
in excess in (a) selected from the group consisting of amine
and anhydride.
45 The healing agent should preferably be in liquid form so
that upon breakage of the microcapsules, it will flow. It may
be liquid in pure form or dissolved in a (preferably low
viscosity) liquid solvent.
In a specific embodiment of the self-healing polymer
50 material, the polyimide matrix (a) is formed by the reaction
of a diamine and a dianhydride, wherein either the diamine
or dianhydride is in excess, and if the diamine is in excess
the polyimide has an excess of reactive amine end groups,
and if the dianhydride is in excess the polyimide has an
55 excess of reactive anhydride end groups. There can also be
other ways of leaving reactive amines or anhydrides on a
polymer.
In a specific embodiment, the healing agent of the micro-
capsules comprises a PAA.
In a specific embodiment, the microcapsules comprise an
60 outer wall and an inner compartment; wherein the outer wall
is a polyimide, and the inner compartment comprises a PAA;
and wherein the polyimide is formed from the PAA.
In a specific embodiment of the self-healing polymer
material with a polymer matrix having reactive end groups
65 and microcapsules with a healing agent having the comple-
mentary reactive end group, the microcapsules further com-
prise a solvent in which the healing agent is dissolved.
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Polyimide Matrix with Microcapsules Comprising a Low-
Melt Polyimide Healing Agent
Another self-healing embodiment for polyimide that we
have developed is placing microcapsules in a polyimide
matrix, where the microcapsules contain a low-melt poly- 5
imide dissolved in solvent. Damage to the matrix and the
microcapsules will release the solvent-soluble polyimide,
which can heal the damage.
Traditional polyimides are very inert to solvents and do
not melt. We have developed a new set of polyimides
described above that were originally developed for use as 10
films for the manual repair of high performance electrical
wire insulation. See U.S. Patent Application Publication US
2011/0212334 entitled "Low-Melt Poly(amic acids) and
Polyimides and their Uses," published on Sep. 1, 2011, and
U.S. Provisional Patent Application Ser. No. 61/658,058 15
entitled "Low-Melt Poly(amic acids) and Polyinrides and
Their Uses," filed on Jun. 11, 2012. In addition to having a
low melting point, these polyimides can be dissolved in
some solvents. These properties can be taken advantage of
in the self-healing of polyimides, including traditional non- 20
melting polyimides.
Microcapsules containing a solvent-soluble polyimide
can be prepared using interfacial or in situ polymerization
techniques. The capsules can be incorporated into a low-
melt polyimide film or matrix, or a traditional non-melt
polyimide film or matrix. The composite materials so 25
formed can be used as a primary electrical wire insulation or
as one of a plurality of layers of a composite wire insulation.
Microcapsules can be prepared as described below and as
described in U.S. Patent Application Publication Numbers
US 2010/0305234 Al entitled "Hydrophobic-Core Micro- 30
capsules and their Formation," published on Dec. 2, 2010,
and US 2010/0320421 Al entitled "Hydrophilic-Core
Microcapsules and their Formation," published on Dec. 23,
2010.
The microcapsules are preferably incorporated into a
low-melt polyimide matrix that has good or at least minimal 35
solubility with the solvent used to dissolve the polyimide
making up the fluid inside the microcapsule. If the matrix
also at least partially dissolves in the solvent it will give
better intermingling of the polymer strands and better bond-
ing. After the microcapsules break releasing the solvent and 40
dissolved low-melt polyimide, the solvent evaporates over
time to leave behind a condensed healed polymer having
superior bonding and physical properties.
Thus, one embodiment provides a self-healing polymer
material comprising: (a) a polyimide matrix; and (b) micro- 45
capsules dispersed in the polyimide matrix and having a wall
and an inner compartment, the inner compartment compris-
ing a solvent and a low-melt polyimide having a melting
temperature below 200° C.
Low-melt polyimides can be prepared as described above
and in U.S. Patent Application Publication US 2011/ 50
0212334 entitled "Low-Melt Poly(amic acids) and Polyim-
ides and their Uses," published on Sep. 1, 2011, and U.S.
Provisional Patent Application Ser. No. 61/658,058 entitled
"Low-Melt Poly(amic acids) and Polyimides and Their
Uses," filed on Jun. 11, 2012. They can be prepared, for 55
instance, by polymerization of monomers comprising: a
diamine monomer comprising repeating alkyleneoxy seg-
ments of 2 to 6 carbon atoms or repeating siloxy segments
and having a molecular weight of between 250 and 3,000.
The use of end caps that shorten the length of the polyimides 
60(such as MAA, succinic anhydride, and other monoanhy-
drides, or monoamines) also yield low-melt polyimides,
even without necessarily including diamine monomers com-
prising repeating alkyleneoxy segments of 2 to 6 carbon
atoms or repeating siloxy segments and having a molecular
weight of between 250 and 3,000. 65
In a specific embodiment of the self-healing polymer
material (i.e., comprising: (a) a polyimide matrix; and (b)
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microcapsules dispersed in the polyimide matrix and having
a wall and an inner compartment, the inner compartment
comprising a solvent and a low-melt polyimide having a
melting temperature below 200° C.), the solvent, when
released from the microcapsules, softens the polyimide
matrix and allows for a more intimate bonding of the
low-melt polyimide of the microcapsules with the polyimide
of the matrix.
In a specific embodiment, the polyimide of the polyimide
matrix is a low-melt polyimide that melts at a temperature
below 200° C. (or below 300° C., below 250° C., or most
preferably below 150° C.).
Another embodiment provides a polymer material com-
prising: (a) a polymer matrix; and embedded in the matrix,
(b) microcapsules wherein the microcapsules are formed by
a process comprising reacting a first batch of melamine,
formaldehyde, and PTT to form a first prepolymer, and
polymerizing the first prepolymer to form a first microcap-
sule wall layer. Once this wall has been formed a second
batch of melamine, formaldehyde, and PTT are reacted to
form a second batch of prepolymer and polymerizing the
second batch of prepolymer in the encapsulation process to
form a second wall layer.
It was found that microcapsules can have their inner
contents extracted when coming in contact with various
solvents or can even directly leak their contents during the
casting or manufacture of a polymer composite comprising
microcapsules. Microcapsules formed with a double layer
wall formed as described in this paragraph though, were
found to have much lower leakage when they were cast into
polymer films. Capsule content extraction can also be mini-
mized by performing a post encapsulation treatment via the
use of Melamine. Melamine or other reactive amines or
aldehydes can react with reactive sites on the wall forming
polymer helping to reduce the size of the pores through
which extraction takes place.
In a more specific embodiment, the polymer of the
polymer matrix is a polyimide.
Another embodiment provides the microcapsules them-
selves, where the microcapsules are formed by a process
comprising: reacting a first batch of melamine, formalde-
hyde, and PTT to form a first batch of prepolymer, and
polymerizing the first batch of prepolymer to form a first
wall layer, and adding a second batch of melamine, form-
aldehyde, and PTT to form a second batch of prepolymer
and polymerizing the second batch of prepolymer to form a
second wall layer.
Two potential mechanisms were envisioned for how self-
healing microcapsules might prove useful as a component in
a film, layer, or coating. Depending on the content of the
microcapsules, aid to self-healing could be accomplished by
having either: 1) capsule content flowing out to fill the
damaged area, or 2) capsule content combining/dissolving
with the bulk film material to aid in its ability to flow and
heal itself. Microcapsules with both types of core content
were prepared. Early films prepared with filled microcap-
sules had inferior physical properties. It was determined that
the core content of the capsules had been transported out into
the body of the film through a solvent extraction mechanism.
This "extraction" occurs when the capsules are mixed with
the starting PAA/solvent solution and the wet film is cast and
set aside to dry. But we have found that microcapsule walls
that were resistant to solvent extraction could be prepared by
using a mixture of melamine, formaldehyde, and PTT as the
shell wall material.
Table 2 outlines the variations in preparation conditions
used in an effort to produce microcapsule walls which
resisted leaching of the inner core content in PAA/solvent
solutions. The general procedure used for microcapsule
preparation follows.
The desired amount of water and desired surfactant are
charged to a beaker. This solution is stirred via a shaft stir
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paddle and warmed to the desired temperature. The desired added if the shell wall materials are to be added at this time.
amounts of shell wall prepolymer components are then The emulsion is allowed to stabilize by stirring at speed and
added if early prepolymer preparation is desired. If prepoly- temperature for 5-10 minutes. The acid catalyst is then
mer components are added at this time, they are allowed to added. A second shell wall prepolymer solution is added
react completely before the oil phase is added. The stir speed 5 5-10 minutes after catalyst addition if multiple layers of
is increased to the desired amount and the oil phase is added. shell polymer are desired. Further shell wall prepolymer
A separately prepared shell wall prepolymer can now be additions can be made for more layers.
TABLE 2
Microencapsulation Investigation: Preparation Conditions vs Microcapsule Quality
Water
Sample Phase Oil Phase WP/ Wall Cat. Stir
Item ID STJ# (WP) (OP) OP Material. Amt.. Speed Comments
1 STJI I-96b 100/1 30 g 3.3/1 2 S -- post E 2 900 Good capsules,
McBenzoate free flowing, fast
acetone extraction;
fast NMP ext.
2 11-96a 100/1 30 g 3.3/1 1.5 S - pre E; 2 1000 Capsules clumped
McBenzoate 1 S PC together - occurred
after PC wall mtl.
addn.
3 17-1 100/1 30 g 3.3/1 2 S -- post E 1 800 Not free flowing,
McBenzoate fast acetone ext.
4 17-5b 100/1 30 g 3.3/1 2 S - post E 2 1000 No PTT, good
McBenzoate capsules, free
flow, fast acetone
extraction
5 17-7 100/1 30 g 3.3/1 2 S - Pre E 2 900 Capsules clumped
McBenz/PI together
6 17-8 140/1 30 g 4.7/1 2 S - Pre E 1 900 Free flowing, fast
McBenz/PI acetone ext.
7 17-10 150/2 30 g 5/1 1 S - Post E; 2 800 Free Flowing,
McBenz/PI 1 S - PC medium acetone
ext. slow or no
DMF ext.
8 17-13 150/2 30 g 5/1 1 S - Post E; 1 800 Poorer capsules,
McBenz/PI 1 S - PC raspberry like.
Very high
acetone ext.
9 17-14 150/2 30 g 5/1 1 S - Post E; 4 800 Similar to 7.
McBenz/PI 1 S - PC Poorer yield.
Water Phase—deionized water with Poly(Na ethylenemaleic anhydride) polymer surfactant grams water used and percentage
of surfactant
Solvent NMP
Oil Phasemethyl benzoate or polyimide in methyl benzoate (MeBenz/Pl), all contained —0.01% solvent 30 blue dye.
Wall Material Melamine (M), Formalin (F), and PTT crosslinlcer; at a standard ratio (S) of (2.0/4.25/0.67)g; amount of each
(IS 
,
1 , 2S, etc.) and mode of addition; wall material can be added at three different points in the process - Pre emulsion (Pre E),
post emulsion (post E), and post catalyst (PC)
Catalyst amount (Cat. Amt.)—milliliters of 10% 112SO4 added
Stir Speed—revolutions per minute (RPM)
45
Materials Development Film and Microcapsule Combina-
tions
Table 3 highlights composites obtained by mixing various
batches of microcapsules with flowable polyimide film. The
results reported point out the importance of using micro-
50 capsules with shell walls that are resistant to solvent (e.g.,
DMF and NMP) extraction. Confirmation of microcapsule
healing agent core content before addition to the polymer
matrix was observed by fourier transform infrared spectros-
copy (FT-IR) and scanning electron microscopy (SEM).
TABLE 3
Polvimide Film and Microcapsule Composites.
Microcapsule Compoite
Polyimide Film, Sample ID Film, Sample Capsule Core
Item Sample ID STJ# STJ# ID STJ# Material Film Observations
1 Polyimide STJ15-13, STJII-73a Siloxane & Some capsule
BPADA/XTJ-542/ODA STJ14-42 Catalyst agglomeration, many
(Table 1, Item 4) empty capsules
2 Polyimide STJ13-42 STJII-73b McBenzoate Capsule agglomeration
BPADA/XTJ-542/ODA
(Table 1, Item 4)
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TABLE3-continued
Polvimide Film and Microcapsule Composites.
Microcapsule Compoite
Polyimide Film, Sample ID Film, Sample Capsule Core
Item Sample ID STJ# STJ# ID STJ# Material Film Observations
3 Polyimide STJII-82 STJII-85-1 McBenz/PI Capsule agglomeration,
BPADA/XTJ-542/ODA sticky
(Table 1, Item 4)
4 Polyimide STJII-82 STJII-85-2 McBenzPI Better capsule
BPADA/XTJ-542/ODA/MAA dispersion, sticky
(Table 1, Item 3)
5 Polyimide STJ13-38a N/A McBenzoate Excellent capsule
BPADA/XTJ-542/ODA/MAA dispersion, normal
(Table 1, Item 3) film, capsules
survive pressing
6 Polyimide STJII-91 N/A McBenzoate Good capsule dispersion,
BPADA/XTJ-542/ODA/MAA weak capsules which
(Table 1, Item 3) crushed upon pressing
7 Polyimide STJII-96b STJ17-2b McBenzoate Good capsule dispersion,
BPADA/XTJ-542/ODA/MAA blue film due to core
(Table 1, Item 3) leaching
8 Polyimide STJ17-10 STJ17-10b McBenz/PI Excellent capsule dispersion,
BPADA/XTJ-542/ODA/MAA no film color change,
(Table 1, Item 3) capsules survive pressing
Materials Development Laminates
Another embodiment provides a laminate composite
structure comprising: two strong polymer film layers, each
in contact with a flowable self-healing polymer film layer
between the two strong polymer film layers; wherein the
strong polymer film layers are mechanically stronger than
the self-healing polymer film layer; wherein upon a break or
cut through the three polymer film layers, the self-healing
polymer flows to form an air-tight seal in the composite
structure; wherein the self-healing polymer layer is, or
comprises, a polyimide, polyurea, polyurethane, polyamide
or polyester.
By the term "film" here, it is meant a layer of polymer
from 10 microns to 5 millimeters thick.
In a particular embodiment of the laminate composite
structure, the polymer of at least one of the two strong
polymer film layers is, or comprises, a polyimide. In a more
specific embodiment, the polyimide is an aromatic polyim-
ide.
In a particular embodiment of the laminate composite
structure, the polymer of the self-healing polymer film layer
is a polyimide. In a more specific embodiment, this Poly-
imide is an aromatic polyimide.
In a specific embodiment of the aromatic polyimide in
either the strong layer or the self-healing polymer film layer,
the aromatic polyimide is formed by reaction of monomers
that comprise one or more aromatic diamine or aromatic
dianhydride monomers and one or more flexible long-chain
diamine or flexible long chain dianhydride monomers,
wherein the mole ratio of aromatic monomers to flexible
long chain monomers is between 5:2 and 2:5.
In a more specific embodiment, the monomers further
comprise an end cap monomer.
25 In a specific embodiment of the aromatic polyimide, the
flexible long chain aliphatic monomers comprise a polyether
or a polysiloxane, such as XTJ-542 or DAPS.
In a specific embodiment of the aromatic polyimide the
aromatic monomers comprise BPADA.
In other specific embodiments of the laminate composites,3o the self-healing polymer layer is, or comprises, a polyimide
or a polyurea.
In other specific embodiments of the laminate composites,
the self-healing polymer layer is a PAA.
In other specific embodiments of the laminate composites,
35 the self-healing polymer layer is a polyurea or polyurethane
and comprises IPDI monomer residues.
Another embodiment provides a fluid-containing object
comprising: a wall comprising the laminate composite struc-
ture described above, wherein the laminate composite struc-
ture surrounds or holds a fluid.
40 In a particular embodiment, the fluid is a gas. In a more
specific embodiment, the fluid-containing object is an inflat-
able enclosure or habitat.
Another embodiment provides a wire comprising: a cen-
tral metal conductor surrounded by polymer insulation;
45 wherein the polymer insulation comprises the laminate
composite structure described above.
Several 3-layer, laminate-like composites (FIG. 7) were
prepared consisting of two outer structural films separated
by a central layer of self-healing film and compared to a
reference Room-Temperature-Vulcanizing (RTV) material
50 as the middle, inner layer. The structural films used were
KAPTON or OASIS polyimide, an in-house prepared Poly-
imide manual repair film (Polyimide BPADA/DAPS/ODA/
MAA; Table 1, Item 1), or MYLAR. These laminates, which
are listed in Table 4, were evaluated to determine if the
central layer would perform in the same flowable/self-
healing manner as the films on glass as shown in FIGS. 1-5.
TABLE 4
3-Layer Laminate Composites.
Top & Bottom Central Self Total
Item Structural Layer Healing Layer thickness (mil) Comments
1 KAPTON (2 mil) Polyimide 14 Strongly adhered
BPADA/DAPS
(Table 1, Item 26)
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TABLE 4-continued
3-Laver Laminate Composites.
Top & Bottom Central Self Total
Item Structural Layer Healing Layer thickness (mil) Comments
2 Siloxane Polyimide Polyimide 26
Flexible (SPIF) BPADA/XTJ-542/ODA/MAA
(Table 1, Item 3)
(150° C.)
3 SPIT Polyimide N/A Strong wrinkling
BPADA/XTJ-542/ODA/MAA and contraction
(Table 1, Item 3)
(200° C.)
4 KAPTON (2 mil) Polyurea N/A Polyurea
IPDI/XTJ-542
(Table 1, Item 22)
5 SPIT Polyimide 17 Film/microcapsule
(Table 3, Item 8) composite
6 SPIT Polyurea 33
IPDI/XTJ-542
(Table 1, Item 22)
7 MYLAR Polyimide 8
BPADA/XTJ-542/ODA/MAA
(Table 1, Item 8)
8 KEVLAR Polyimide 21
9 SPIT 739 RTV 33
10 SPIT 3140 RTV 27
11 SPIT 3145 RTV 36
FIG. 8 indicates puncture damage and the progress of
self-healing of one such laminate. Self-healing of the punc-
ture proceeds quickly in this structure as compared to the
self-healing flow observed in simple "film on glass" cuts.
As the materials described in this patent are intended to
represent high performance composites to be used in avia-
tion and space applications it is important to determine their
thermal, mechanical, and chemical stability, as well as the
required time for self-healing.
Thermal Stability Testing
It is desired that any material utilized in aerospace appli-
cations have good thermal properties. Films cured or imi-
dized at both 150° C. and 200° C. are included to understand
effects on thermal stability by increasing curing tempera-
tures.
Industry typically reports TGA thermal stability data as
the temperature at which a 5% weight loss of the material is
observed. TGA data for films representing three variations of
the standard flowable polyimide formula (BPADA/XTJ-
542/ODA/MAA (Table 1, Item 2); BPADA/XTJ-542/ODA/
MAA (Table 1, Item 3 cured at 150° C.); and BPADA/XTJ-
542/ODA/MAA (Table 1, Item 3 cured at 200° C.) were
found to have significant differences in their thermal stabil-
ity (FIG. 9). TGA data of siloxane polyimide flexible (SPIF),
which is a film designed for electrical wire insulation
repairs, is also given for reference.
In an attempt to achieve more complete imidization and
crosslinking, polymers were made using the basic formula-
tion with several variations of the end cap chemistry. Table
5 shows the TGA information obtained for these various
polymers. Polymers BPADA/XTJ-542/ODA (Table 1, Items
4) and BPADA/XTJ-542/DAD (Table 1, Item 7) were pre-
pared without end caps. These two films exhibited the best
thermal stability at a 5% weight loss temperature of approxi-
mately 367° C. All polymer films with end caps exhibited
5% weight loss temperatures of approximately 335° C.
except the polymer which was designed to deliver a very low
molecular weight.
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TABLE 5
Thermal Stability of Polvimides Test 1
30
Temperature for 5%
Material weight loss (° C.)
Polyimide BPADA/XTJ-542/ODA/MAA 331
(Table 1, Item 3)
35 Polyimide BPADA/XTJ-542/ODA 369
(Table 1, Item 4)
Polyimide BPADA/XTJ-542/ODA 258
(Table 1, Item 5)
Polyimide BPADA/XTJ-542/ODA/C8Succan 339
(Table 1, Item 6)
40 Polyimide BPADA/XTJ-542/DAD 367
(Table 1, Item 7)
Polyimide BPADA/XTJ-542/ODA/MAA 331
(Table 1, Item 8)
Polyimide BPADA/XTJ-542/ODA/MAA/Succan 316
(Table 1, Item 9)
Polyimide BPADA/XTJ-542/ODA/Succan 332
45 (Table 1, Item 10)
Table 6 is a compilation of polymers in which changes in
a dianhydride or aromatic diamine were made. No signifi-
50 cant improvements in thermal stability (or self-healing) were
observed by these changes. The "baseline" polymer repre-
sented by polyimide BPADA/XTJ-542/ODA/MAA (Table
1, Item 3) exhibited the best thermal stability of this group
55 
of polymers.
60
Material
TABLE 6
Thermal Stability of Polvimides Test 2
Temperature for 5%
weight loss (° C.)
Polyimide BPADA/XTJ-542/ODA/MAA 331
(Table 1, Item 3)
Polyimide BPDA/XTJ-542/ODA/Succan 294
(Table 1, Item 16)
65 Polyimide BPADA/XTJ-542/TDA/Succan 325
(Table 1, Item 17)
US 10,174,198 B2
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TABLE 6-continued
Thermal Stability of Polvimides Test 2
Temperature for 5%
Material weight loss (° C.)
Polyimide BPADA/XTJ-542/DAS0/Succan 314
(Table 1, Item 18)
Polyimide BPADA/XTJ-542/DABA/Succan 304
(Table 1, Item 19)
Table 7 presents the thermal stability data of several
polyureas and urethanes prepared as potential self-healing
films. Most of these had diminished thermal stability when
compared to polyimides; however, the polyurea (Table 1,
Item 22) with a 5% weight loss temperature of 299° C.
performed as well as some polyimides.
TABLE 7
Thermal Stabilitv Test for Polymeas
Temperature for 5%
Material weight loss (° C.)
Polymea TDI/DAPS 243
(Table 1, Item 21)
Polymea IPDI/XTJ-542 299
(Table 1, Item 22)
Polymea IPDI/DAPS 275
(Table 1, Item 23)
Polymea IPDI/Siloxane Diet 227
(Table 1, Item 24)
Table 8 shows the 5% weight loss data for several
polymer films that had microcapsules added. The microcap-
sule loading for each film was approximately 25% (by
weight).
TABLE 8
Thermal Stabilitv Test for Polvimides with Microcapsules Added
Temperature for 5%
Material weight loss (° C.)
Polyimide BPADA/XTJ-542/ODA/MAA 331
(Table 1, Item 3)
Polyimide BPADA/XTJ-542/ODA 369
(Table 1, Item 4)
Polyimide BPADA/XTJ-542/ODA 196
(Table 3, Item 1)
Polyimide BPADA/XTJ-542/ODA/MAA 243
(Table 3, Item 5)
Polyimide BPADA/XTJ-542/ODA 304
(Table 3, Item 3)
Polyimide BPADA/XTJ-542/ODA/MAA 231
(Table 3, Item 4)
Polyimide BPADA/XTJ-542/ODA/MAA 285
(Table 3, Item 7)
Polyimide BPADA/XTJ-542/ODA/MAA 246
(Table 3, Item 8)
FIG. 10 highlights the differences between the three
different aspects of these film/microcapsule composites. As
expected, the highest thermal stability is exhibited by the
film itself, lowest are the microcapsule components, and
intermediate is the film/capsule composite.
Mechanical Stability Testing
Samples of each material underwent tensile testing using
an Instron Model 3344 Universal Testing Machine. Each
sample was cast, baked, and cut using a razor blade into
rectangular strips approximately 6 mm wide and 0.3 mm
thick.
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The mechanical data collected indicates that many of the
self-healing/flowable films are very elastic and have exten-
sions at break ranging from 150-420 mm. Films containing
microcapsules were less elastic, with extension at break
5 averaging 103 mm.
Healing Time versus Thickness Flat Surfaces
A series of tests were conducted to determine the healing
rate of thin films of various thicknesses versus time. Three
film thicknesses, 5, 10, and 15 mils, were evaluated as part
to of this testing. Each film sample was placed on a microscope
slide to provide a rigid surface to allow surface damage to
the films. The damage was induced using a 0.500 mm
diameter needle. The five film materials evaluated as part of
this testing were polyimide BPADA/XTJ-542/ODA/MAA
15 (Table 1, Item 3, cured at 150° C.), polyimide BPADA/XTJ-
542/ODA/MAA (Table 1, Item 3, cured at 200° C.), poly-
imide BPADA/XTJ-542/ODA/MAA (Table 1, Item 3, cured
at 150° C.), BPADA/XTJ-542/ODA/MAA (Table 1, Item 2,
cured at 150° C.), and polyimide BPADA/XTJ-542/ODA/
20 MAA with microcapsules added (Table 3, Item 5, cured at
150° C.). The healing rate was monitored and photographed
at regular intervals using a Caltex optical microscope.
The data indicate that several of the film materials have
potential for use in self-healing, flexible systems. The films
25 that performed best were polyimide BPADA/XTJ-542/
ODA/MAA (Table 1, Item 3, cured at 150° C.), polyimide
BPADA/XTJ-542/ODA/MAA (Table 1, Item 3, cured at
200° C.), and polyimide BPADA/XTJ-542/ODA/MAA
(Table 1, Item 8, cured at 150° C.). Both polyimide BPADA/
30 XTJ-542/ODA/MAA (Table 1, Item 3, cured at 200° C.) and
polyimide BPADA/XTJ-542/ODA/MAA (Table 1, Item 8,
cured at 150° C.) showed significant healing after 4 hours
when thicknesses of material was at least 10 mils. Polyimide
BPADA/XTJ-542/ODA/MAA (Table 1, Item 3, cured at
35 150° C.) showed significant healing after 24 hours when
thickness of material was at least 10 mils. It should be noted
that the damage size was a key variable and it was very
difficult to induce consistent damages to each material under
evaluation. Pictorial representation of a flowable film that
40 was able to self-heal damage without the use of external
stimulus in less than 24 hours, without scarring is shown in
FIG. 11. Further demonstration of the self-healing/flowable
properties of these systems is shown in the time-lapse
images (shown in FIGS. 12 and 13) taken after inducing
45 surface damage using a 0.5 mm diameter needle. FIG. 12
shows the healing/sealing of damage for polyimide BPADA/
XTJ-542/ODA/MAA (Table 1, Item 3, cured at 150° C.).
FIG. 13 shows the healing/sealing of damage for BPADA/
XTJ-542/ODA/MAA (Table 1, Item 3, cured at 200° C.). It
50 should be noted that the damage was only to the surface of
the materials (approximately 25% of the sample thickness)
and that the study only lasted 3 minutes due to limitations of
the time-lapse software. After 24 hours both samples were
completely healed.
55 Tests were also conducted to determine healing rates of
thin films coated onto various substrates. The substrates used
in these tests were copper-coated KAPTON, aluminum-
coated PTFE, and OASIS film, and the two film materials
evaluated were polyimide BPADA/XTJ-542/ODA/MAA
60 (Table 1, Item 3) and polyimide BPADA/XTJ-542/ODA/
MAA (Table 1, Item 8).
The data indicate that the substrate to which the self-
healing materials are bonded influences the rate of self-
healing for the system. For example, polyimide BPADA/
65 XTJ-542/ODA/MAA (Table 1, Item 8) partially heals when
bonded to copper-coated KAPTON but does not heal at all
when bonded to aluminum-coated PTFE. Also, polyimide
US 10,174,198 B2
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BPADA/XTJ-542/ODA/MAA (Table 1, Item 3) does not
show significant healing when bonded to either copper-
coated KAPTON or OASIS film, but does heal when placed
on a glass microscope slide.
Healing Time for Laminate Systems Pressure Study
The laminate-like test specimens were cut into 45 mm
diameter circles for evaluation in a pressure testing appara-
tus. Each cut specimen was placed in the test apparatus and
the system was pressurized to 19.5 psi to determine if there
were any leaks present. Once the system was shown to be
pressure tight, the specimen under evaluation was removed
from the testing apparatus, punctured with a 0.500 mm
needle, and allowed to stand at room temperature (approxi-
mately 22° C.) for the specified time before re-testing.
The data indicate that several of the laminate composites
show promise for use in self-healing/sealing inflatable sys-
tems. The laminate composites IPDI/XTJ-542 (Polyurea;
Table 1, Item 22) and BPADA/XTJ-542/ODA/MAA (Poly-
imide; Table 1, Item 3, cured at 150° C.) performed best of
the systems evaluated. The system containing polyurea
IPDI/XTJ-542 (Table 1, Item 22) sealed in 2 hours (or less)
and the system containing polyimide BPADA/XTJ-542/
ODA/MAA (Table 1, Item 3, cured at 150° C.) sealed in 4
hours (or less). The laminate composite containing polyim-
ide BPADA/DAPS (Table 1, Item 26) sealed in 24 hours (or
less). It should be noted that the exact time required to seal
is not known since measurements were made at predeter-
mined intervals.
The self-healing polymer materials described herein do
not need to comprise a polymerization catalyst in order to
self-heal. This is one advantage of the materials. Thus, the
polymer materials preferably do not comprise a polymer-
ization catalyst. Preferably neither the polymer matrix nor
the microcapsules embedded in the polymer matrix com-
prise a polymerization catalyst.
Another embodiment of the invention provides a polyim-
ide formed by polymerization of monomers consisting
essentially of:
(a) BPADA, DAPS, ODA, and MAA, in a BPADA/
DAPS/ODA/MAA mole ratio of about 9:8:2:2;
(b) BPADA, XTJ-542, ODA, and MAA in a BPADA/
XTJ-542/ODA/MAA mole ratio of about 9:7:3:2;
(c) BPADA, XTJ-542, and ODA in a BPADA/XTJ-542/
ODA mole ratio of about 10:7:3 to about 8:7:3;
(d) BPADA, XTJ-542, ODA, and C8Succan in a BPADA/
XTJ-542/ODA/C8Succan mole ratio of about 9:7:3:2;
(e) BPADA, XTJ-542, and DAD in a BPADA/XTJ-542/
DAD mole ratio of about 9:6:4;
(f) BPADA, XTJ-542, ODA, and MAA in a BPADA/XTJ-
542/ODA/MAA mole ratio of about 9:7:3:1;
(g) BPADA, XTJ-542, ODA, MAA, and Succan in a
BPADA/XTJ-542/ODA/MAA/Succan mole ratio of
about 9:7:3:1:1;
(h) BPADA, XTJ-542, ODA, and Succan in a BPADA/
XTJ-542/ODA/Succan mole ratio of about 9:6.5:3.5:2;
(i) BPADA, XTJ-542, TDA, and Succan in a BPADA/
XTJ-542/TDA/Succan mole ratio of about 9:7:3:2; or
(j) BPADA, XTJ-542, DASO, and Succan in a BPADA/
XTJ-542/DASO/Succan mole ratio of about 9:7:3:2.
Another embodiment provides a polyurea or polyurethane
formed by polymerization of monomers consisting essen-
tially of:
(a) IPDI and XTJ-542 in a mole ratio of about 9:10;
(b) IPDI and DAPS in a mole ratio of about 9:10; or
(c) IPDI and siloxane diol in a mole ratio of about 9:10.
Although specific embodiments have been illustrated and
described herein, it will be appreciated by those of ordinary
30
skill in the art that any arrangement that is calculated to
achieve the same purpose may be substituted for the specific
embodiments shown. Many adaptations of the invention will
be apparent to those of ordinary skill in the art. Accordingly,
5 this application is intended to cover any adaptations or
variations of the invention. It is manifestly intended that this
invention be limited only by the following claims and
equivalents thereof.
10 
We claim:
1. A polymer material comprising:
a polymer matrix that flows at approximately 23° C., or
about room temperature, wherein the polymer of the
polymer matrix is formed by polymerization of mono-
15 mers comprising:
(a) a diamine monomer comprising repeating alkyle-
neoxy segments of 2 to 6 carbon atoms or repeating
siloxy segments and having a molecular weight of
between 250 and 3,000; and
20 (b) a dianhydride monomer;
wherein the polymer material is a film or layer 50 microns
to 5 mm thick and when the film or layer is cut into two
pieces, and the two pieces placed laterally in contact
with or near to each other, the pieces of the film or layer
25 
flow back together at approximately 23° C., or about
room temperature within 30 days and molecularly
combine.
2. The polymer material of claim 1, wherein the dianhy-
dride monomer is an aromatic dianhydride.
3. The polymer material of claim 1, wherein the dianhy-
dride monomer is bisphenol A dianhydride (BPADA), biphe-
nyl dianhydride (BPDA), or benzophenone-3,3',4,4'-tetrac-
arboxylic dianhydride.
4. The polymer material of claim 3, wherein the mono-
35 mers further comprise an aromatic diamine monomer
selected from the group consisting of ODA, TDA, and
DASO.
5. The polymer material of claim 3, wherein the dianhy-
dride monomer is BPADA.
40 6. The polymer in of claim 5, wherein the mono-
mers further comprise an end capping group that is a
monoamine or a monoanhydride.
7. The polymer material of claim 1, wherein the mono-
mers further comprise an aromatic diamine monomer.
8. The polymer material of claim 7, wherein the aromatic
45 
diamine monomer is oxydianiline (ODA), thiodianiline
(TDA), or dianilinesulfone (DASO).
9. The polymer material of claim 1, wherein the mono-
mers further comprise an end capping group.
50 
10. The polymer material of claim 9, wherein the end
capping group is not cross-linkable.
11. The polymer material of claim 9, wherein the end
capping group is a monoamine or monoanhydride.
12. The polymer material of claim 11, wherein the end
55 
capping group is maleic anhydride (MAA), succinic anhy-
dride (Succan), or C8-succinic anhydride (C8Succan).
13. The polymer material of claim 12, wherein the end
capping group is MAA.
14. The polymer material of claim 1, wherein the mono-
60 
mers further comprise ODA, TDA, DASO, or diaminodo-
decane (DAD).
15. The polymer material of claim 1, wherein the mono-
mers further comprise a diamine selected from the group
consisting of ODA, TDA, DASO, and diaminododecane
65 (DAD); and the monomers further comprise a monoamine or
monoanhydride.
